NCT01665209View on ClinicalTrials.gov

Bioequivalence Study of Morphine Sulfate 60 mg Extended-Release Tablets Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2006

Study Completion Date

December 31, 2006

Conditions
Healthy
Interventions
DRUG

Morphine Sulfate

Morphine Sulfate 60mg Extended-release tablets

All Listed Sponsors
lead

Ranbaxy Inc.

INDUSTRY

NCT01665209 - Bioequivalence Study of Morphine Sulfate 60 mg Extended-Release Tablets Under Fed Conditions | Biotech Hunter | Biotech Hunter